Adicet Bio, Inc.
Symbool: ACET
NASDAQ
1.69
USDMarktprijs vandaag
-0.5143
Koers/Winst Verhouding
0.0002
Koers/Winst Groei Verhouding
138.87M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Adicet Bio, Inc. (ACET) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 780.07 | 159.7 | 257.7 | 277.5 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 1.23 | 0 | 0.4 | 0.2 | ||||||||||||||||
balance-sheet.row.inventory | 6.39 | 0 | 2.6 | 4.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 3.94 | 2.6 | 0.4 | 0 | ||||||||||||||||
balance-sheet.row.total-current-assets | 791.62 | 162.3 | 261 | 282.4 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 188.76 | 44.2 | 49 | 35 | ||||||||||||||||
balance-sheet.row.goodwill | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | -0.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.85 | 0.8 | 1.2 | 2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 231.54 | 45 | 69.7 | 56.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1023.16 | 207.3 | 330.7 | 338.9 | ||||||||||||||||
balance-sheet.row.account-payables | 12.56 | 2.6 | 4.4 | 3.3 | ||||||||||||||||
balance-sheet.row.short-term-debt | 12.34 | 3.2 | 2.5 | 1.6 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 76.52 | 17.7 | 18.5 | 19.4 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 51.09 | 13.4 | 12.8 | 6.7 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 77.04 | 17.8 | 18.6 | 19.5 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 85.64 | 17.7 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.total-liab | 153.03 | 37.1 | 38.4 | 35.8 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 338.9 | ||||||||||||||||
balance-sheet.row.common-stock | 0.02 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -1302.45 | -380.8 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | -338.9 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1637.35 | 550.9 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 487.95 | 207.3 | -199.8 | -132.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 487.95 | - | - | - | ||||||||||||||||
Total Investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.total-debt | 88.86 | 20.9 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.net-debt | -691.21 | -138.8 | -236.6 | -256.6 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.66 | -142.7 | -69.8 | -62 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.1 | 6.1 | 2.6 | 1.5 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 9.71 | -34.1 | 0 | 1.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 20.26 | 20.3 | 17.1 | 12.5 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0.25 | 0.3 | 2.7 | -6.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0.2 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 2 | ||||||||||||||||
cash-flows.row.account-payables | -1.68 | -1.7 | 1.7 | 1.1 | ||||||||||||||||
cash-flows.row.other-working-capital | 1.94 | 1.9 | 0.8 | -9.2 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 12.62 | 56.5 | 2.6 | 1.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -93.72 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 10.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4.46 | -4.5 | -16.8 | -2.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.39 | 0.4 | 43.4 | 238.1 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.15 | -0.1 | -3.2 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0.08 | -0.1 | -1.9 | 4.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.24 | 0.2 | 41.5 | 242.7 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -97.94 | -97.9 | -20 | 188.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 780.07 | 159.7 | 257.7 | 277.7 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 878.01 | 257.7 | 277.7 | 88.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -93.72 | -93.7 | -44.8 | -51.1 | ||||||||||||||||
cash-flows.row.capital-expenditure | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.free-cash-flow | -98.18 | -98.2 | -61.5 | -64.1 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 25 | 9.7 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 8.14 | 6.1 | 5 | 0 | ||||||||||||||||
income-statement-row.row.gross-profit | -8.14 | -6.1 | 20 | 9.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 106.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.53 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.operating-expenses | 130.89 | 126.5 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 132.58 | 132.6 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.interest-income | 9.98 | 10 | 3.8 | 0.1 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 7.3 | 6.1 | 2.8 | -0.5 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -120.41 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -152.04 | -132.6 | -72.6 | -61.4 | ||||||||||||||||
income-statement-row.row.income-before-tax | -142.66 | -142.7 | -69.8 | -62.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.51 | 0 | -2.8 | -0.1 | ||||||||||||||||
income-statement-row.row.net-income | -141.4 | -142.7 | -67 | -62 |
Vaak gestelde vragen
Wat is Adicet Bio, Inc. (ACET) totale activa?
Adicet Bio, Inc. (ACET) totale activa is 207295000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.000.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.000.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.000.
Wat is Adicet Bio, Inc. (ACET) nettowinst (netto-inkomen)?
De nettowinst is -142658000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 20924000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 126478000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 159711000.000.